Stay updated on SB3 vs. Herceptin® in HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the SB3 vs. Herceptin® in HER2+ Breast Cancer Clinical Trial page.
Latest updates to the SB3 vs. Herceptin® in HER2+ Breast Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, while removing the previous wording about those conducting the study.SummaryDifference3%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe website has added new features for user interaction while removing extensive details about participant groups, interventions, and various data fields available for download.SummaryDifference5%
- Check23 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading study data in various formats and additional participant and study information fields.SummaryDifference5%
- Check37 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
- Check44 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.2%
- Check66 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.1%
Stay in the know with updates to SB3 vs. Herceptin® in HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SB3 vs. Herceptin® in HER2+ Breast Cancer Clinical Trial page.